Evidence map›Paper›PMID 42059639›Full record

ArticleInfection and immunity2026

Immunological mechanism behind reactivated cryptococcosis in persistently infected mice following FTY720 treatment.

Michiko Yoshida, Ko Sato, Nana Nakahata, Hayato Sato, Reina Ohagi, Emi Kanno, Hiromasa Tanno, Keiko Ishii, Tetsuji Aoyagi, Atsuo Kikuchi and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Michiko YoshidaDepartment of Pediatrics, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.ORCID 0000-0002-4783-7233
Ko SatoDepartment of Clinical Microbiology and Infection, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.ORCID 0000-0002-5548-6285
Nana NakahataDepartment of Clinical Microbiology and Infection, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Hayato SatoDepartment of Clinical Microbiology and Infection, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Reina OhagiDepartment of Clinical Microbiology and Infection, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Emi KannoDepartment of Translational Science for Nursing, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Hiromasa TannoDepartment of Translational Science for Nursing, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Keiko IshiiDepartment of Clinical Microbiology and Infection, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Tetsuji AoyagiDepartment of Clinical Infectious Diseases, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Atsuo KikuchiDepartment of Pediatrics, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Kazuyoshi KawakamiDepartment of Clinical Microbiology and Infection, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.

Funding

Chiba University 20-02Chiba University 21-04Japan Agency for Medical Research and Development JP19jm0210073Japan Agency for Medical Research and Development JP20jm0210073Japan Agency for Medical Research and Development JP21jm0210073Japan Agency for Medical Research and Development JP22jm0210073Japan Society for the Promotion of Science 18H02851Japan Society for the Promotion of Science 19K17920Japan Society for the Promotion of Science 21H02965Japan Society for the Promotion of Science 21K16314
6 · The paper itself

Abstract

The

Indexed as

CryptococcosisCryptococcus neoformansFingolimod HydrochlorideImmunosuppressive AgentsPersistent InfectionPropylene GlycolsSphingosineAnimalsCD4-Positive T-LymphocytesDisease Models, AnimalFemaleGranulomaInterferon-gammaInterleukin-12LungMiceFingolimod HydrochlorideImmunosuppressive AgentsInterferon-gammaInterleukin-12Propylene GlycolsSphingosinecryptococcosisFTY720latent infectionreactivation

Identifiers

PMID42059639
PMCPMC13248744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.